CN1440802A - Gastritis treating Chinese medicine - Google Patents
Gastritis treating Chinese medicine Download PDFInfo
- Publication number
- CN1440802A CN1440802A CN 03121266 CN03121266A CN1440802A CN 1440802 A CN1440802 A CN 1440802A CN 03121266 CN03121266 CN 03121266 CN 03121266 A CN03121266 A CN 03121266A CN 1440802 A CN1440802 A CN 1440802A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- preparation
- rhizoma
- gastritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The present invention relates to gastritis treating Chinese medicine which is prepared with bupleurum root, white peony root, licorice, lesser galangal rhizome, nutagrass flatsedge rhizome, bitter organe, inula flower, curcumna root and corydalis tuber.
Description
Technical field the present invention relates to a kind of Chinese medicine for the treatment of gastritis, particularly the Chinese medicine of being made by Radix Bupleuri, the Radix Paeoniae Alba, Radix Glycyrrhizae, Rhizoma Alpiniae Officinarum, Rhizoma Cyperi, Fructus Aurantii, sweet Flos Inulae, Radix Curcumae, Rhizoma Corydalis.
Background technology the present invention relates to treat the Chinese medicine preparation of gastritis, and the traditional Chinese medical science thinks, stomach is a sun soil, main being received and digesting food, with reduce to suitable; Feelings will is unsuccessful, and diseases caused by exogenous pathogenic factor pathogenic factor, or eating and drinking without temperance cut down the gas that injures one's stomach, and causes depression of liver-QI perverse and unreasonable manner criminal stomach, causes incoordination between the liver and stomach.Incoordination between the liver and stomach is held the criminal's of trembling with fear stomach under the arm, so disease sees that flatulence pain or pain scurry two sides of body, likes warm pain relieved by pressing or mouthful general clear saliva or meets angry recurrence or increase the weight of appetite stimulator; Incoordination between the liver and stomach is done frequently so disease is seen belch, noisy pantothenic acid, abdominal distention; Sick at edema caused by disorder of QI event white and thin fur, double dyspepsia then tongue is thick in vain; Sick liver, the main pain of belonging to is so see stringy pulse.Dialectically scurry two sides of body and to like warm pain relieved by pressing be characteristics with gastral cavilty distending pain or pain.Irritability is held the criminal's of trembling with fear stomach under the arm, wooden prosperous insult spleen, and incoordination between the liver and stomach, gastral cavilty distending pain or pain are scurried two sides of body and are liked warm pain relieved by pressing; So control suitable: depressed liver-energy dispersing and QI regulating, stomach warming pain relieving.Have in the market some the treatment gastritis Chinese medicine, some belongs to cures the symptoms, not the disease, some uses expensive composition, some in application process since uncertain therapeutic efficacy cut interrupt the use.The invention provides a kind of determined curative effect, safe ready, little, the cheap pure traditional Chinese compound medicine of side effect.
Summary of the invention the invention provides a kind of Chinese medicine preparation of being made by Radix Bupleuri, the Radix Paeoniae Alba, Radix Glycyrrhizae, Rhizoma Alpiniae Officinarum, Rhizoma Cyperi, Fructus Aurantii, sweet Flos Inulae, Radix Curcumae, Rhizoma Corydalis.Chinese medicine preparation of the present invention has depressed liver-energy dispersing and QI regulating, the effect of stomach warming pain relieving.Be applicable to the liver-stomach disharmony type chronic superficial gastritis; Cure mainly the gastral cavilty distending pain or scurry two sides of body bitterly, belch is done frequently, noisy pantothenic acid, and body of the tongue is light red, white and thin fur or thick in vain, stringy pulse.Or meet angry recurrence or increase the weight of, or appetite stimulator, or abdominal distention.Remove Rhizoma Chuanxiong by bupleurum powder for relieving liver-qi in the prescription of the present invention, add Flos Inulae, Rhizoma Corydalis, Radix Curcumae, Rhizoma Alpiniae Officinarum and form.Bupleurum powder for relieving liver-qi cures mainly depression of liver-QI must not catharsis, and perverse and unreasonable manner is violated stomach, the card of incoordination between the liver and stomach; Rhizoma Chuanxiong, " must join the wood grass " day: " the fire stagnation headache is forbidding all for fiery acute fullness in the epigastrium and abdomen, insufficiency of the spleen lack of appetite ", assertive evidence has insufficiency of the spleen lack of appetite, dies it.Compound in the side " Liang Fu Wan " is that holding concurrently can be soothing the liver because Liang Fu Wan cures mainly irritability or the visitor criminal of trembling with fear stomach, and merit is specially controlled stomach." the stomach being liable to sending digested food downward ", gastric qi is suitable to reduce to, and Gu Fangzhong adds the Flos Inulae sending down the abnormal ascending QI and removes.Hyperactive liver-QI attacking the stomach, incoordination between the liver and stomach, stagnation of QI and blood may bring about pain, thus add with Rhizoma Corydalis, Radix Curcumae with circulation of qi promoting, invigorate blood circulation, pain relieving.Gu Er in the stagnation of QI gastritis granule side, reaches mechanism of qi with Radix Bupleuri (bitter flat, as to go into liver, gallbladder meridian) dispersing the stagnated live-QI to relieve the stagnation of QI, accent, removes stagnant heat thoroughly, and be to be monarch drug.The Radix Paeoniae Alba (bitter, acid, is slightly cold; Go into liver, spleen lung three warps) be minister, nourishing blood to suppress the hyperactive liver, relieving spasm to stop pain, Radix Bupleuri and the Radix Paeoniae Alba two medicines are harmonious, and loose and receive and usefulness, and the liver body must be supported, and liver is used to such an extent that transfer.Liver is lost bar and reaches, and stasis is fallen ill, so side Rhizoma Cyperi (suffering, little hardship, flat; Go into liver, tri-jiao channel), Fructus Aurantii (bitter, acid, is slightly cold; Go into spleen, stomach two warps) dredge the promoting the circulation of QI machine, with Rhizoma Alpiniae Officinarum (hot, hot, as to go into the taste warp) warming stomach for dispelling cold pain relieving, use Rhizoma Corydalis (hot, bitter, warm; Go into pericardium, liver, spleen, lung meridian) the blood circulation promoting regulates qi pain relieving, (hot, bitter, cold with Radix Curcumae; Go into the heart, liver, lung meridian) removing heat from blood have a respite resolving depression, function of gallbladder promoting, (hot, bitter, salty, warm with Flos Inulae; Go into lung, large intestine channel) sending down the abnormal ascending QI, expectorant, remove the adjuvant drug in the side of being all.Radix Glycyrrhizae is an adjuvant, and coordinating the actions of various ingredients in a prescription share with the Radix Paeoniae Alba, but relieving spasm to stop pain.So there are depressed liver-energy dispersing and QI regulating, the effect of stomach warming pain relieving in full side.Chinese medicine preparation of the present invention, its prescription consists of: Radix Bupleuri 110-440 part Radix Paeoniae Alba 220-880 part Radix Glycyrrhizae 110-440 part Rhizoma Alpiniae Officinarum 110-440 part Rhizoma Cyperi 220-880 part Fructus Aurantii 110-440 part honey Flos Inulae 220-880 part Radix Curcumae 166-666 part Rhizoma Corydalis 165-660 part is Radix Bupleuri 165-293 part Radix Paeoniae Alba 330-586 part Radix Glycyrrhizae 165-293 part Rhizoma Alpiniae Officinarum 165-293 part Rhizoma Cyperi 330-586 part Fructus Aurantii 165-293 part honey Flos Inulae 330-586 part Radix Curcumae 249-444 part Rhizoma Corydalis 247-440 part during more preferably 333 parts of Rhizoma Corydalis of 440 parts of Fructus Aurantiis of 220 portions of Rhizoma Cyperis of 220 portions of Rhizoma Alpiniae Officinarums of 440 portions of Radix Glycyrrhizaes of 220 portions of Radix Paeoniae Albas of Radix Bupleuri, 440 portions of Radix Curcumaes of 220 parts of sweet Flos Inulae are formed more than 330 parts preferably, weight is calculated with crude drug, if with the gram is unit, this composition can be made into 1000 doses of pharmaceutical preparatioies, the final drug preparation that described 1000 doses of fingers are made, as make 1000 of capsule preparations, 1000 in tablet, 1000 bags of granules, oral liquid 1000 ampoules etc., also can make big packing as granule, as the 100-500 bag, specifically can be 100 bags, 125 bags, 200 bags, 250 bags, 500 bags etc., every bag can be used as taking dose 1 time.More than form, as if being unit with the gram, can be made into the preparation of 50-1000 taking dose, as tablet, make 1000, each taking dose can be the 1-20 sheet, can take 50-1000 time altogether.As granule, make 125 bags, take the 1-2 bag at every turn, can take 62.5-125 time altogether.More than form to be by weight as proportioning, when producing, can increase or reduce according to corresponding proportion, as large-scale production can be unit with the kilogram, or be unit with the ton, small-scale production can be a unit with milli part also, weight can increase or reduce, but the constant rate of the raw medicinal herbs weight proportion between each composition.The ratio of above weight proportion obtains through science screening, and for especial patient, the proportioning of can corresponding adjustment forming increases or reduce being no more than 100%.Single medicinal material, especially ministerial drug and adjuvant drug in more than forming also can be replaced by the suitable Chinese medicine with identical property of medicine, and its drug effect of the Chinese medicine preparation after the replacement is constant.Chinese medicine preparation of the present invention, can add the medicine acceptable carrier when being prepared into medicament, described medicine acceptable carrier can be: starch, sucrose, lactose, mannitol, silicon derivative, cellulose and derivant thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, soil temperature 80, agar, calcium carbonate, calcium bicarbonate, surfactant, Polyethylene Glycol, cyclodextrin, beta-schardinger dextrin-, phospholipid material, Kaolin, Pulvis Talci, calcium stearate, magnesium stearate etc.Chinese medicine preparation of the present invention can be any pharmaceutically useful dosage form, and these dosage forms comprise: tablet, sugar coated tablet, film coated tablet, enteric coated tablet, capsule, hard capsule, soft capsule, oral liquid, suck agent, granule, electuary, pill, powder, unguentum, sublimed preparation, suspensoid, powder, solution, injection, suppository, ointment, plaster, cream, spray, drop, patch.Preparation of the present invention, peroral dosage form preferably, as: capsule, tablet, oral liquid, granule, pill, powder, sublimed preparation, unguentum etc., preferably granule.Preparation of the present invention is determined usage and dosage according to patient's situation in use, but obeys every day three times, each 1-20 agent, as: 1-20 bag or grain or sheet.Chinese medicine preparation of the present invention prepares by the following method.More than nine the flavor, get Rhizoma Alpiniae Officinarum, Rhizoma Cyperi, Radix Curcumae, Fructus Aurantii extraction volatile oil, aqueous solution after distillation device is in addition collected, the Radix Paeoniae Alba, Rhizoma Corydalis are with 50% alcohol reflux three times, each 1 hour, reclaim ethanol, get filtrate, medicinal residues and Radix Bupleuri, Radix Glycyrrhizae, Flos Inulae decoct secondary, and 2 hours for the first time, 1.5 hours for the second time, aqueous solution after decocting liquid and the distillation is merged, be concentrated into relative density extractum of (80 ℃) more than 1.40, this extractum adds medicine acceptable auxiliary, promptly can be made into Chinese medicine preparation of the present invention by the ordinary preparation technology.As make granule, and get 1 part of extractum, 0.6 part in dextrin, in 60-70 ℃ of drying, granulate sprays into volatile oil, mixing, and is airtight, and packing is promptly.Below by effect experiment beneficial effect of the present invention is described.Test used medicine for the medicine that the method according to the embodiment of the invention 1 prepares, be called stagnation of QI gastritis granule, positive control uses the YUANHU ZHITONG KELI agent, WEISU CHONGJI, and experimental result sees Table 1-6.Table 1 stagnation of QI gastritis granule is to the granulomatous influence of the rat scraps of paper (X ± SD, n=8) the heavy suppression ratio of group dosage granuloma
(g/kg) (mg) the saline group compares under (%) normal saline 164.2 ± 40.2 stagnation of QI gastritis granule I 54.9 63.8 ± 19.2*** 61.1 stagnation of QI gastritis granule II 35.9 76.3 ± 19.2*** 53.5 hydrocortisone 0.04 55.0 ± 16.7*** 66.5***P＜0.01 and the physiology, the t check
As seen from Table 1, stagnation of QI gastritis granule has the obvious suppression effect to the scraps of paper granuloma of rat.Table 2 stagnation of QI gastritis granule is to influence (X ± SD, n=10) the heavy suppression ratio of group dosage granuloma of mice paper ear swelling
(g/kg) (mg) (%) normal saline 3.7 ± 1.4 stagnation of QI gastritis granule I 54.9 2.2 ± 1.0** 40.5 stagnation of QI gastritis granule II 35.9 2.2 ± 1.6** 40.5 hydrocortisone 0.04 1.2 ± 0.7*** 67.6**P＜0.05
* *Compare with the normal saline group P＜0.01, and t checks as seen from Table 2, and stagnation of QI gastritis granule can obviously resist dimethylbenzene induced mice ear swelling.Table 3 stagnation of QI gastritis granule to the influence of mice hot plate reaction (X ± SD, n=10)
The dosage pain threshold, (second) increase rate group, (g/kg) after the front administration of administration, (%) physiological saline 20.4 ± 5.2 19.8 ± 3.8*, 3.0 Qichiweiyan Granules I, 65.4 20.4 ± 6.9 29.1 ± 9.9**, 42.6 Qichiweiyan Granules II, 43.4 20.4 ± 4.3 27.5 ± 6.2***, 34.8 YUANHU ZHITONG KELI agent 5.0 19.8 ± 6.8 34.6 ± 12.1*** 74.7*P＞0.05**P＜0.05* *P＜0.01 is checked as seen from Table 3 with comparing t before the administration, and stagnation of QI gastritis granule and YUANHU ZHITONG KELI agent are compared respectively with before the administration, and notable difference is all arranged, and shows that stagnation of QI gastritis granule has the suppression pain to act on.Influence (X ± SD, n=10) the group dosage writhing response number of times suppression ratio of table 4 stagnation of QI gastritis granule Dichlorodiphenyl Acetate induced mice writhing response
(g/kg) (inferior/only) (%) normal saline 30.1 ± 6.9 stagnation of QI gastritis granule I 65.1 13.6 ± 3.6*** 54.8 stagnation of QI gastritis granule II 43.4 16.1 ± 5.4*** 46.5 YUANHU ZHITONG KELI agent 5.0 13.0 ± 3.7*** 56.8
* *Compare with the normal saline group P＜0.01, and t checks as seen from Table 4, and stagnation of QI gastritis granule can obviously reduce the runic reaction times, shows that this medicine has analgesic activity.Table 5 stagnation of QI gastritis granule is to influence (X ± SD, n=10) the group dosage methyl orange stomach residual rate of mice gastric emptying motion
(g/kg) (%) normal saline 15.2 ± 6.6 stagnation of QI gastritis granule I 49.2 39.8 ± 24.0*** stagnation of QI gastritis granule II 32.8 30.5 ± 18.9** atropine 0.005 44.7 ± 5.5**P＜0.05
* *Compare with the normal saline group P＜0.01, and t checks as seen from Table 6, and stagnation of QI gastritis granule can obviously improve methyl orange residual rate under one's belt, and the gastric emptying of slowing down is arranged.Influence (X ± SD, n=10) the group dosage ulcer index healing rate of the stagnant infections of rat chronic stomach due to table 6 stagnation of QI gastritis granule Dichlorodiphenyl Acetate
(g/kg) (mm) (%) normal saline 2.20 ± 1.3 stagnation of QI gastritis granule I 24.6 0.40 ± 0.7*** 81.8 stagnation of QI gastritis granule II 16.4 0.45 ± 0.8*** 79.5 WEISU CHONGJI 15.0 0.85 ± 1.2** 61.4**P＜0.05
* *P＜0.01 and normal saline group relatively, t check as seen from Table 7, stagnation of QI gastritis granule has work and promotes rat chronic gastric ulcer healing effect due to the acetic acid, WEISU CHONGJI also has similar effect, it acts on and slightly is inferior to stagnation of QI gastritis granule.The specific embodiment further specifies the present invention by the following examples
Preparation prescription Radix Bupleuri 220g Radix Paeoniae Alba 440g Radix Glycyrrhizae 220g Rhizoma Alpiniae Officinarum 220g Rhizoma Cyperi (vinegar system) 440g Fructus Aurantii (parched) 220g honey Flos Inulae (cloth wraps into and fries in shallow oil) the 440 Radix Curcumae 333g Rhizoma Corydalis 330g of embodiment 1 granule make above nine flavors of 1000g granule altogether, get Rhizoma Alpiniae Officinarum, Rhizoma Cyperi, Radix Curcumae, Fructus Aurantii is extracted volatile oil, aqueous solution after distillation device is in addition collected, the Radix Paeoniae Alba, Rhizoma Corydalis is with 50% alcohol reflux three times, each 1 hour, reclaim ethanol, get filtrate, medicinal residues and Radix Bupleuri, Radix Glycyrrhizae, Flos Inulae decocts secondary, 2 hours for the first time, 1.5 hours for the second time, aqueous solution after decocting liquid and the distillation is merged, be concentrated into relative density extractum of (80 ℃) more than 1.40, get 1 part of extractum, 0.6 part in dextrin, in 60-70 ℃ of drying, granulate, spray into volatile oil, mixing, airtight, be distributed into 250 bags promptly.
Preparation prescription Radix Bupleuri 220g Radix Paeoniae Alba 440g Radix Glycyrrhizae 220g Rhizoma Alpiniae Officinarum 220g Rhizoma Cyperi (vinegar system) 440g Fructus Aurantii (parched) 220g honey Flos Inulae (cloth wraps into and fries in shallow oil) the 440 Radix Curcumae 333g Rhizoma Corydalis 330g of embodiment 2 capsules make above nine flavors of 1000 capsules altogether, get Rhizoma Alpiniae Officinarum, Rhizoma Cyperi, Radix Curcumae, Fructus Aurantii is extracted volatile oil, aqueous solution after distillation device is in addition collected, the Radix Paeoniae Alba, Rhizoma Corydalis is with 50% alcohol reflux three times, each 1 hour, reclaim ethanol, get filtrate, medicinal residues and Radix Bupleuri, Radix Glycyrrhizae, Flos Inulae decocts secondary, 2 hours for the first time, 1.5 hours for the second time, aqueous solution after decocting liquid and the distillation is merged, be concentrated into relative density extractum of (80 ℃) more than 1.40, get 1 part of extractum, 0.6 part in dextrin, in 60-70 ℃ of drying, granulate, spray into volatile oil, mixing, airtight, 1000 gelatine capsules of packing into.
Preparation prescription Radix Bupleuri 220g Radix Paeoniae Alba 440g Radix Glycyrrhizae 220g Rhizoma Alpiniae Officinarum 220g Rhizoma Cyperi (vinegar system) 440g Fructus Aurantii (parched) 220g honey Flos Inulae (cloth wraps into and fries in shallow oil) the 440 Radix Curcumae 333g Rhizoma Corydalis 330g of embodiment 3 tablets make nine flavors more than 1000 altogether, get Rhizoma Alpiniae Officinarum, Rhizoma Cyperi, Radix Curcumae, Fructus Aurantii is extracted volatile oil, aqueous solution after distillation device is in addition collected, the Radix Paeoniae Alba, Rhizoma Corydalis is with 50% alcohol reflux three times, each 1 hour, reclaim ethanol, get filtrate, medicinal residues and Radix Bupleuri, Radix Glycyrrhizae, Flos Inulae decocts secondary, 2 hours for the first time, 1.5 hours for the second time, the aqueous solution after decocting liquid and the distillation is merged, be concentrated into relative density extractum of (80 ℃) more than 1.40, get 1 part of extractum, 0.6 part in dextrin, in 60-70 ℃ of drying, granulate sprays into volatile oil, mixing, airtight, add magnesium stearate 20g, tabletting is made 1000.
Claims (10)
1. Chinese medicine preparation that prevents and/or treats gastritis, it is characterized in that, make Radix Bupleuri 110-440 part Radix Paeoniae Alba 220-880 part Radix Glycyrrhizae 110-440 part Rhizoma Alpiniae Officinarum 110-440 part Rhizoma Cyperi 220-880 part Fructus Aurantii 110-440 part honey Flos Inulae 220-880 part Radix Curcumae 166-666 part Rhizoma Corydalis 165-660 part by following Chinese medicine raw materials by weight proportion.
2. the Chinese medicine preparation of claim 1, it is characterized in that, make Radix Bupleuri 165-293 part Radix Paeoniae Alba 330-586 part Radix Glycyrrhizae 165-293 part Rhizoma Alpiniae Officinarum 165-293 part Rhizoma Cyperi 330-586 part Fructus Aurantii 165-293 part honey Flos Inulae 330-586 part Radix Curcumae 249-444 part Rhizoma Corydalis 247-440 part by following Chinese medicine raw materials by weight proportion.
3. the Chinese medicine preparation of claim 2, it is characterized in that, make 330 parts of 333 parts of Rhizoma Corydalis of 440 parts of Fructus Aurantiis of 220 portions of Rhizoma Cyperis of 220 portions of Rhizoma Alpiniae Officinarums of 440 portions of Radix Glycyrrhizaes of 220 portions of Radix Paeoniae Albas of Radix Bupleuri, 440 portions of Radix Curcumaes of 220 parts of sweet Flos Inulae by following Chinese medicine raw materials by weight proportion.
4. the Chinese medicine preparation of claim 1-3 is to be fit to medicinal various dosage forms.
5. the Chinese medicine preparation of claim 4 is tablet, capsule, oral liquid, buccal tablet, granule, electuary, pill, powder, suspensoid, powder, solution, drop, drop pill.
6. the Chinese medicine preparation of claim 4 is granules.
7. the Chinese medicine preparation of claim 1 prevents and/or treats application in the medicine of gastritis in preparation.
8. the preparation method of the Chinese medicine preparation of claim 1 is characterized in that, may further comprise the steps:
A. get Rhizoma Alpiniae Officinarum, Rhizoma Cyperi, Radix Curcumae, Fructus Aurantii extraction volatile oil, the aqueous solution after distillation device is in addition collected,
B. the Radix Paeoniae Alba, Rhizoma Corydalis ethanol extraction reclaim ethanol, filtrate, medicinal residues and Radix Bupleuri, Radix Glycyrrhizae, Flos Inulae decoct, and the aqueous solution after decocting liquid and the distillation is merged, concentrated extractum,
C. above-mentioned extractum mixes with the medicine acceptable carrier, makes preparation.
9. the preparation method of claim 8 is characterized in that, in the b step, is 50% ethanol with the employed ethanol of ethanol extraction.
10. the preparation method of claim 8 is characterized in that, in the b step, uses ethanol extraction, refluxes altogether three times.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03121266 CN1236810C (en) | 2003-03-31 | 2003-03-31 | Gastritis treating Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03121266 CN1236810C (en) | 2003-03-31 | 2003-03-31 | Gastritis treating Chinese medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1440802A true CN1440802A (en) | 2003-09-10 |
| CN1236810C CN1236810C (en) | 2006-01-18 |
Family
ID=27770474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03121266 Expired - Lifetime CN1236810C (en) | 2003-03-31 | 2003-03-31 | Gastritis treating Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1236810C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102716460A (en) * | 2012-06-30 | 2012-10-10 | 李承平 | Evil-expelling and depression-resolving combined tablet |
| CN103386093A (en) * | 2013-08-06 | 2013-11-13 | 天津太平洋制药有限公司 | Medicament for treating superficial gastritis |
| CN105381196A (en) * | 2015-12-30 | 2016-03-09 | 邯郸制药股份有限公司 | Health food composition capable of improving digestion |
| CN106138987A (en) * | 2015-04-13 | 2016-11-23 | 周海腾 | A kind of Chinese medicine oral liquid treating gastritis |
-
2003
- 2003-03-31 CN CN 03121266 patent/CN1236810C/en not_active Expired - Lifetime
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102716460A (en) * | 2012-06-30 | 2012-10-10 | 李承平 | Evil-expelling and depression-resolving combined tablet |
| CN103386093A (en) * | 2013-08-06 | 2013-11-13 | 天津太平洋制药有限公司 | Medicament for treating superficial gastritis |
| CN106138987A (en) * | 2015-04-13 | 2016-11-23 | 周海腾 | A kind of Chinese medicine oral liquid treating gastritis |
| CN105381196A (en) * | 2015-12-30 | 2016-03-09 | 邯郸制药股份有限公司 | Health food composition capable of improving digestion |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1236810C (en) | 2006-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103285310A (en) | Use of rhodiola rosea compound composition in preparing medicine for curing gastric ulcer | |
| CN104491052A (en) | Traditional Chinese medicine composition for treating rheumatic and rheumatoid arthritis and preparation method thereof | |
| CN101028446A (en) | Medicine for symptomatic dry eye | |
| CN1236810C (en) | Gastritis treating Chinese medicine | |
| CN104998162A (en) | Medicine for treating cough and preparing method of medicine | |
| CN114377095A (en) | Fructus amomi-sandalwood volatile oil extraction method, capsule for treating gastritis and preparation method of capsule | |
| CN101342282A (en) | Chinese medicinal composition for treating gastropathy and preparation method | |
| CN101480472B (en) | Medicament for reducing blood pressure and regulating blood fat and production method | |
| CN1233364C (en) | Chinese medicine for treating digestive ulcerating sore and its preparation method | |
| CN101194959B (en) | Capsule for treating headache and method for preparing the same | |
| CN104623615A (en) | Medicine for treating asthma | |
| CN1899574A (en) | Chinese medicine composition for preventing and controlling liver cancer and its use | |
| CN105168425B (en) | A kind of Chinese materia medica preparation and preparation method thereof improving immunity | |
| CN111135235A (en) | A composition for preventing and relieving acute alcoholism or alcoholic intoxication | |
| CN114712466B (en) | Medicine with weight-reducing and beautifying effects and preparation method thereof | |
| CN100339093C (en) | Compound medicine for treating coronary heart disease and angina pectoris and its preparing process | |
| CN101385814A (en) | Medicine for treating the coronary heart disease and preparation method thereof | |
| CN112755137B (en) | Traditional Chinese medicine composition for treating mild and moderate knee osteoarthritis and application thereof | |
| CN114903940B (en) | New use of Jingfeng preparation in reducing blood sugar | |
| CN101194958B (en) | Method for preparing decocted ointment for treating headache | |
| CN1220508C (en) | Medicine for curing diseases of digestive system and its preparation method | |
| CN101700323B (en) | Pharmaceutical composition for preventing and treating liver cancer | |
| CN1163252C (en) | Tianjian capsule and its preparing process | |
| CN101194965B (en) | Mastication tablet for treating headache and method for preparing the same | |
| CN1814250A (en) | Chinese medicine composition for treating liver cirrhosis ascites and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP03 | Change of name, title or address |
Address after: 1266 No. 330052 Nanchang Huiren Jiangxi economic and Technological Development Zone Avenue. Patentee after: JIANGXI HUIREN PHARMACEUTICAL CO.,LTD. Address before: 330043 No. 1189, Yingbin Avenue, Nanchang, Jiangxi Patentee before: Jiangxi Huiren Pharmaceutical Co.,Ltd. |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20060118 |